EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Enhanced Gemcitabine Delivery via Metformin-Derived Carbon Dots for Pancreatic Ductal Adenocarcinoma Therapy

Arya Ajith, Christian Agatemor, Jiuyan Chen, Mehrdad Shiri, Zixin Yang, Lydia Dixon, Kun Wang, Roger M. Leblanc

Biomaterials Science · 2026

DOI: 10.1039/d6bm01301e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Arya Ajith und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive cancer with a poor prognosis due to its dense stromal microenvironment, tumor heterogeneity, and rapid development of drug resistance. Gemcitabine (GEM), the...

Zitieren

APA

Ajith, A., Agatemor, C., Chen, J., Shiri, M., Yang, Z., Dixon, L., Wang, K., & Leblanc, R. M. (2026). Enhanced Gemcitabine Delivery via Metformin-Derived Carbon Dots for Pancreatic Ductal Adenocarcinoma Therapy. Biomaterials Science. https://doi.org/10.1039/d6bm01301e

Vancouver

Ajith A, Agatemor C, Chen J, Shiri M, Yang Z, Dixon L, et al. Enhanced Gemcitabine Delivery via Metformin-Derived Carbon Dots for Pancreatic Ductal Adenocarcinoma Therapy. Biomaterials Science. 2026. doi:10.1039/d6bm01301e

BibTeX
@article{Ajith2026,
  author = {Ajith, Arya and Agatemor, Christian and Chen, Jiuyan and Shiri, Mehrdad and Yang, Zixin and Dixon, Lydia and Wang, Kun and Leblanc, Roger M.},
  title = {Enhanced Gemcitabine Delivery via Metformin-Derived Carbon Dots for Pancreatic Ductal Adenocarcinoma Therapy},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d6bm01301e}
}
Kostenlos starten →